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ABSTRACT
Objective: Diabetes mellitus is a disease associated with dysfunction of pancreatic β-cells and oxidative stress. A treatment which can reduce the 
impact of oxidative stress may be beneficial in the treatment of diabetes. Therefore, this study aimed to investigate the effect of gambier extract on the 
levels of malondialdehyde (MDA), superoxide dismutase (SOD), and blood glucose level (BGL) in type 2 diabetes mellitus (T2DM).
Methods: This research was a randomized clinical study consisted of two groups, namely placebo group (n=10) and gambier group (n=6). The blood 
samples were collected from the vein after fasting overnight and before consuming 100 g white bread to measure the levels of MDA, SOD, and BGL. 
The same procedure was conducted after fasting and 2-h postprandial on day 1 and day 14. The data obtained were analyzed with Student’s t-test 
with a statistical significance level of p<0.05.
Results: The results showed that there was no change in MDA levels in the placebo group during the observation, but there was a significant decrease 
in MDA levels in the gambier group on day 14. In contrast, SOD levels increased in all measurements although there was no change on day 1 in the 
placebo group. The present study also found a significant increase of BGLs after consuming 100 g bread in both groups, but less BGL elevation in the 
gambier group.
Conclusion: It is concluded that gambier extract has special mechanisms in the treatment of T2DM as an antioxidant and BGLs reduction.
Keywords: Gambier extract, Catechin, Malondialdehyde, Superoxide dismutase, Blood glucose level, Type 2 diabetes mellitus.
INTRODUCTION
Diabetes mellitus is a metabolic disease characterized by chronic 
hyperglycemia and related to the dysfunction of pancreatic β-cells 
and oxidative stress. Oxidative stress is reported to contribute to the 
dysfunction and effects of antioxidants on the pathogenesis of diabetes [1]. 
This occurs due to the release of superoxide which alters the electron 
transport in the mitochondria and increases the activity of nicotinamide 
adenine dinucleotide phosphate oxidase. Oxidative stress, through the 
production of reactive oxygen species (ROS), has been suggested as 
the root cause underlying the development of type 2 diabetes mellitus 
(T2DM) and the progression of long-term diabetes complications [2]. 
Thus, it is important to find complementary treatments such as herbal 
medicines which can reduce the impact of oxidative stress, so it will be 
beneficial in the treatment of diabetes. Gambier or Uncaria tomentosa 
(Ut, Cat’s claw) has antioxidant characteristics [3].
The polyphenol catechins have strong radical-scavenging and 
antioxidative effects. These effects may contribute to the prevention of 
diseases such as diabetes [1].
Catechins may treat diabetes and its complications with the modification 
of oxidative stress [4]. It was reported previously that the consumption 
of catechin-rich green tea slightly inhibited postprandial elevation of 
blood glucose level (BGL) and oxidative products in postmenopausal 
women [5]. This finding suggests that the intake of green tea containing 
catechins could reduce the risk of type 2 diabetes. Among many 
medicinal plants which have been used for treatment, this research 
used a plant which was well known to the public, namely gambier in 
the form of extract. Gambier is an herbal medicine which is rich in 
antioxidants such as catechins.
Therefore, the present study aimed to investigate the effect of gambier 
(Uncaria Gambir Roxb.) extract on malondialdehyde (MDA), superoxide 
dismutase (SOD), and BGL in T2DM patients.
METHODS
This study has received ethical approval from the Health Research 
Ethical Committee in University of Sumatera Utara (No:572/TGL/
KEPKFK USU-RSUP HAM/2017). The study group consisted of 
uncontrolled T2DM subjects with metformin monotherapy. The 
inclusion criteria were T2DM, aged between 35 and 70 years old, BGL 
at fasting >126 mg/dl, and the 2-h postprandial >200 mg/dl, whereas 
the exclusion criteria were the subjects consumed other antidiabetics, 
glycated hemoglobin (HbA1C) <7, and had a history of kidney or liver 
disease. The subjects recruited in the study had a 14-day follow-up with 
daily monitoring of drug consumption by phone. In addition, the time of 
administration, dosages, and presence or absence of the side effects of 
metformin or gambier extract were also monitored. 16 T2DM patients 
were randomly assigned to two treatment groups, namely the placebo 
group (500 mg metformin + placebo) (n=10) and the gambier group 
(500 mg metformin + 375 mg gambier extract) (n=6). All drugs were 
consumed twice a day.
After fasting overnight and before consuming 100-g white bread, vein 
blood samples were collected to measure MDA, SOD, and BGL levels of 
the subjects. The same procedure was conducted at the 2-h postprandial 
on day 1 and day 14.
BGL levels were determined with the glucose oxidase method while MDA 
and SOD concentrations were determined with spectrophotometric 
assay kit. All procedures were performed according to the 
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manufacturer’s instructions. BGL levels were measured by the GLUC 2 
Roche procedures. MDA levels were measured using thiobarbituric acid 
assay (R and D System procedures), whereas SOD levels were measured 
using the BioAssay system procedures.
The data obtained were presented as a mean ± standard deviation. 
Student’s t-tests were performed for mean comparisons. p<0.05 was 
considered as statistically significant.
RESULTS
The general characteristics of subjects participated in the present 
study are presented in Table 1. There were no significant differences 
in all variables measured before the intervention for the placebo and 
gambier groups.
Table 2 summarizes the changes in the levels of MDA, SOD, and BGL 
on the day of observation. There was a declining trend in MDA levels 
in both groups. However, there was only a significant decrease in MDA 
levels in the gambier group on day 14 (p=0.001). In addition, MDA levels 
in the gambier group were lower than the placebo group. Overall, there 
was no significant difference, except the MDA level in the gambier group 
was significantly lower than the placebo group at the 2-h postprandial 
on day 14.
On the other hand, the levels of SOD significantly (p<0.05) increased 
in all measurements, but there was no change only on the 1st day in 
the placebo group. Furthermore, SOD levels were higher in the gambier 
group than in the placebo group, but it was not statistically significant 
(p>0.05) (Table 2).
2 h after consuming 100 mg white bread, all BGLs were significantly 
increased (Table 2)
Table 3 summarizes data about the levels of MDA, SOD, and BGL based 
at the fasting hour and 2-h postprandial on the observation day. As 
shown, there were significantly higher MDA levels at fasting hour on 
day 14 than on day 1 in both groups. However, there was no difference 
(p=0.35) in MDA levels at the 2-h postprandial between day 1 and day 
14 in the gambier group.
In contrast, Table 3 also summarizes that there was no significant 
difference in SOD levels between day 1 and day 14, but SOD levels at 
the fasting hour on day 14 were significantly higher than on day 1 in 
the gambier group.
As shown in Table 3, there was a significant lower in the BGLs at fasting 
hour in both groups. The 2-h postprandial BGL was only lower in the 
gambier group.
Table 4 summarizes the percentage of decreasing MDA levels; 
however, no significant difference was found in the percentage of 
decrease in MDA levels for each treatment between day 1 and day 
14, although the percentage of decrease in MDA levels was two times 
higher in gambier group. But there was a significant difference in the 
percentage of decreasing MDA levels between the gambier group 
compared to the placebo group on day 14.
In the placebo group, the percentage of increase in the SOD levels was 
markedly on day 14, but it was not statistically significant compared to 
that on day 1. On the contrary, in the gambier group, the percentage of 
increase in SOD levels on day 14 was lower than that on day 1. Although 
the percentage of increase in SOD levels in the gambier group was 
higher than the placebo group, a significant difference was only found 
on day 1 (Table 4).
The percentage of increase in BGL at the 2-h postprandial occurred in 
both groups; however, there was a double increase of BGL in the placebo 
group (p=0.02). There was no significant of the percentage increase in 
BGL between two groups.
Table 1: Baseline data of participants before an intervention in 
both groups (placebo group and gambier group)
Variable Group p
Placebo Gambier
Number of subjects  
(male/female)
10 (6/4) 6 (3/3) -
Age (year old) 53.50±8.54 54.83±10.78 0.788
Education
Academic 3 3
High school 7 3
BMI 23.75±4.65 25.31±3.74 0.499
High (cm) 157.50±10.99 161.83±12.40 0.478
Weight (kg) 59.60±11.34 63.33±9.44 0.510
HbA1C 10.97±2.37 9.8±1.98 0.329
0.71±0.10 0.68±0.06 0.575
SOD (U/ml) 5.33±1.58 5.37±2.13 0.448
Fasting blood glucose 
level (mg/dl)
238.50±87.64 234.00±72.71 0.917
AST (SGOT) (U/L) 15.50±4.84 25.67±15.96 0.191
ALT (SGPT) (U/L) 26.50 16.40±8.50 0.072
Ureum (mg/dl) 32.15±13.51 24.87±13.14 0.310
Creatinine (U/L) 1.05±0.61 0.95±0.52 0.411
Time diagnosed (year) 5.90±1.39 7.50±2.08 0.510
Abdominal circle (cm) 89.40±10.93 92.33±12.48 0.629
BMI: Body mass index, HbA1C: Glycated hemoglobin, SOD: Superoxide 
dismutase, AST: Aspartate aminotransferase, SGOT: Serum glutamic oxaloacetic 
transaminase, ALT: Alanine transaminase, SGPT: Serum glutamic-pyruvic 
transaminase
Table 2: The levels of malondialdehyde, superoxide dismutase, and blood glucose on the day of observation
Variable Day 1 p Day 14 p
Fasting hour 2‑h postprandial Fasting hour 2‑h postprandial
Malondialdehyde (nmol/dl)
Placebo 0.71±0.10 0.67±0.18 0.36 1.05±0.62 0.82±0.09 0.44
Gambier 0.68±0.06 0.60±0.20 0.12 0.91±0.10 0.67±0.04 0.001*
p 0.58 0.23 0.19 0.001*
Superoxide dismutase (U/ml)
Placebo 5.33±1.58 5.76±2.14 0.39 4.29±2.27 5.73±2.81 0.001*
Gambier 5.36±2.13 8.19±2.18 0.03* 5.82±1.95 8.84±4.11 0.02*
p 0.45 0.13 0.07 0.09
Blood glucose (mg/dl)
Placebo 238.50±87.4 329.30±125.71 0.001* 196.00±88.64 333.90±73.89 0.001*
Gambier 234.00±72.71 326.33±67.49 0.001* 194.33±53.76 302.83±55.71 0.001*
p 0.92 0.96 0.59 0.39
*Significance (p<0.05)
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DISCUSSION
To the best of our knowledge, the present study was the first to examine 
the effect of gambier extract intake on oxidative stress (MDA and 
SOD) and BGL in uncontrolled T2DM patients. At the baseline data, all 
participants were completely uncontrolled T2DM with the fasting BGL 
hyperglycemia >200 mg/dl (238.50±87.64 mg/dl in the placebo group 
and 234.00±72.71 mg/dl in the gambier group). The HbA1C values for 
both groups were higher than 7 (10.97±2.37 in the placebo group and 
9.8±1.98 in the gambier group). There were similar values found in 
the variables measured between the two groups (p>0.05) as shown in 
Table 1.
A complementary and alternative medicine has been used by many 
diabetic patients in the world. The herbal medicine gambier (Cat’s 
claw) is used as CAM because it is rich in catechin. Gambier, which is 
called Asen-‘yaku in Japan, previously, has a role in the normalization 
of BGL [6]. Another study demonstrated that daily consumption of 
green tea which is rich in catechin decreased serum MDA-low-density 
lipoprotein concentrations [7].
The present study showed that there was a decreasing trend in MDA 
levels in both groups. However, there was no statistically significant 
change in MDA levels for the placebo group during the observation, but 
there was a significant decrease in MDA levels in the gambier group 
only on day14 (p<0.05) (Table 2).
As shown in Table 3, the comparison of MDA levels at fasting hour and 
2-h postprandial demonstrated that there were significant higher MDA 
levels at fasting hour on day 14 than day 1 in both groups (p<0.05). In 
contrast, in the gambier group, there was no difference found (p=0.35) in 
MDA levels at the 2-h postprandial between day 1 and day 14 (Table 3).
In addition, the levels of MDA in the gambier group appeared to be lower 
than the placebo group. Although there was no significant difference, 
the levels of MDA in the gambier group were significantly lower than 
the placebo group at the 2-h postprandial on day 14 (Table 2).
The percentage of decrease in MDA levels on day 14 was double 
compared to that on day 1; however, it was not statistically significant 
(Table 4). Furthermore, there was a significant difference in the 
percentage of decrease in MDA levels on day 14 between the placebo 
group (−7.14±26.52%) and the gambier group (−25.66±8.56%). This 
evidence indicates that gambier containing catechin suppressed the 
production of MDA after 2 weeks of ingestion.
The in vitro study of Manju et al. (2013) demonstrated that catechin 
were found in Acorus calamus rhizome. The total phenol content 
was expressed as mg of catechin/g of extract and the corresponding 
values for A. calamus methanolic and aqueous extract was found to be 
12.17±1.47 mg/g and 19.86 ± 1.45 mg/g respectively. [8].
An animal study found that SOD activity significantly increased after 
an intraperitoneal administration, but catechins administration had 
no effect on MDA levels which remained stable during the study. SOD 
activity showed a moderate negative correlation with glutathione 
peroxidase activity [9].
This study also found that the levels of SOD increased in all 
measurements, and only no change was found on the 1st day of 
the placebo group. In addition, the levels of SOD were higher in the 
gambier group than in the placebo group, but it was not statistically 
significant (p>0.05) (Table 2). Table 3 summarizes that the levels of 
SOD at fasting hour on day 14 were higher significantly than on day 
1 in the gambier group. In contrast, Table 3 also summarizes that 
there was no significant difference in SOD levels between day 1 and 
day 14, except the fact that SOD levels at fasting hour on day 14 were 
significantly higher than day 1 in the gambier group. The percentage of 
increase in SOD levels in the gambier group was higher than that in the 
placebo group; in particular, the percentage of increase in SOD levels in 
the gambier group on day 1 was 6 times higher than that in the placebo 
group (Table 4).
This is supported by a study conducted by Widodo et al. using herbal 
medicine Nigella sativa seed extract doses of 125 and 250 mg/kg 
showed antihyperglycemic effects, increased antioxidant activity, as 
well as pancreatic regeneration of organ damage in alloxan-induced 
diabetic rats [10]. While, Farias et al. found no differences in oxidative 
stress of the antioxidant enzyme SOD in colorectal cancer patients with 
and without the gambier therapy [11].
Catechin was identified as the major bioactive compound in gambier. 
One of the main importances is that the antioxidant in gambier is safe. 
The dose of catechin dependently decreased the serum levels of MDA 
and increased SOD in the catechin-treated diabetic groups versus the 
untreated diabetic group (p<0.05) [4]. The present study, however, was 
not able to demonstrate this phenomenon because of the relatively low 
dose of gambier extract used (375 mg).
Table 3: The levels of malondialdehyde, superoxide dismutase, and blood glucose based on the fasting hour and 2‑h postprandial
Variable Fasting hour p 2‑h postprandial p
Day 1 Day 14 Day 1 Day 14
Malondialdehyde
Placebo 0.71±0.10 1.05±0.62 0.001* 0.67±0.18 0.82±0.09 0.001*
Gambier 0.68±0.06 0.91±0.10 0.001* 0.60±0.20 0.67±0.04 0.35
Superoxide dismutase
Placebo 5.33±1.58 4.29±2.27 0.07 5.76±2.14 5.73±2.81 0.95
Gambier 5.36±2.13 5.82±1.95 0.03* 8.19±2.18 8.84±4.11 0.58
Blood glucose
Placebo 238.50±87.64 196.00±88.64 0.001* 329.30±125.71 333.90±73.89 0.80
Gambier 234.00±72.71 194.33±53.76 0.04* 326.33±67.49 302.83±55.71 0.02*
*Significance (p<0.05)
Table 4: The percentage of change in the levels of 
malondialdehyde, superoxide dismutase, and blood glucose in 
the placebo and gambier group
Variable Day 1 Day 14 p
Malondialdehyde
Placebo −7.17±20.63 −7.14±26.52 0.29
Gambier −13.13±27.15 −25.66±8.56 0.35
p 0.33 0.05
Superoxide dismutase
Placebo 9.75±23.42 34.86±26.86 0.07
Gambier 59.74±41.78 47.46±18.17 0.57
p 0.001* 0.33
Blood glucose
Placebo 37.52±6.00 84.77±36.75 0.02*
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Catechins are dietary polyphenolic compounds associated with a 
wide variety of beneficial health effects in vitro, in vivo, and clinical. 
These therapeutic characteristics have been attributed to catechins’ 
antioxidant and free radical scavenging effects. Another herbal 
medicine, cocoa contains polyphenolic components, such as catechin, 
epicatechin, and procyanidin B2. These components have strong 
antioxidative activity and may improve type 2 diabetes [12].
Ramirez-Sanches et al. (2013) examined oxidative stress-related 
alterations in skeletal muscle of heart failure and type 2 diabetes 
patients when compared with healthy controls and evaluated the effect 
of 3-month treatment with (-)-epicatechin rich cocoa (ERC). There were 
severe alterations in oxidative stress regulatory systems in the skeletal 
muscle of heart failure and type 2 diabetes patients when compared 
with healthy controls. Treatment with (-)-ERC induced recovery in 
glutathione levels and increased in SOD [13].
It is suggested that the fluctuating blood glucose concentrations, as 
those observed during postprandial glycemic excursions in people with 
T2DM, may contribute significantly to oxidative stress. Oxidative stress 
has been implicated as the underlying cause of both the macrovascular 
and microvascular complications associated with T2DM and developing 
diabetes [2].
On the other hand, the present study showed that there was a 
significant increase in BGL after consuming 100 g bread in both groups, 
but there was no significant difference in BGL between the two groups 
(Table 2). Table 3 summarizes that BGLs were significantly lower on 
day 14 than on day 1. However, no change in BGLs was found at the 
2-h postprandial in the placebo group. The percentage of increase 
in BGL at the 2-h postprandial in the placebo group was double and 
statistically significant (p=0.02). The percentage of increase in BGL 
between the two groups was not significant (Table 4). The present 
study also demonstrated that gambier extract suppressed the elevation 
of BGL postprandially. Other study showed that the intake of catechin-
rich green tea slightly inhibited an increase in the postprandial BGLs 
and oxidative products in postmenopausal women [5]. These effects 
suggest that the intake of green tea containing catechins could reduce 
the risk of type 2 diabetes.
CONCLUSION
The present study showed that an acute ingestion of catechins containing 
herbal gambier reduced MDA levels and the 2-h postprandial plasma 
glucose concentrations, but it increased SOD levels in uncontrolled 
T2DM patients. The present findings also indicate that the intake of 
gambier extract containing catechins improves the 2-h postprandial 
hyperglycemia and redox homeostasis in uncontrolled T2DM patients.
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